We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

April 27, 2011

Genzyme Corporation v. Endo Pharmaceuticals Inc.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


  1. April 27, 2011

    Genzyme Sues Over Endo's Bid To Sell Generic Renvela

    Genzyme Corp. on Wednesday filed suit in Maryland accusing Endo Pharmaceuticals Inc. of infringing its patent covering Renvela by seeking approval to sell a generic version of the kidney disease treatment before the patent expires.


To view the parties, register now.